PAVMZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
No signals from the correlation tool

Stats
今日成交量	15 400
平均成交量	0
市值	7.23M
EPS	$-1.750 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0 (0.00%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-05-04	O'neil Shaun	Sell	25 935	Common stock
2022-02-22	O'neil Shaun	Sell	0	Common stock
2022-02-22	O'neil Shaun	Sell	195 108	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	100 000	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	75 000	Employee stock option (right to buy)

INSIDER POWER
100.00
Last 14 transactions
Buy: 2 950 000 \| Sell: 396 043

相关性 (AI algo v.1.1b): Paired value (算法实时跟踪最相关股票的变化并提供即时更新)

PAVmed Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PAVmed Inc 财务报表

Annual	2023
营收:	$2.45M
毛利润:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
营收:	$2.45M
毛利润:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
营收:	$377 000
毛利润:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
营收:	$500 000
毛利润:	$-85 000.00 (-17.00 %)
EPS:	$-1.150

Financial Reports:

No articles found.

PAVmed Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company\'s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett\'s Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.